Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 453

1.

Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.

Bae KT, Zhou W, Shen C, Landsittel DP, Wu Z, Tao C, Chapman AB, Torres VE, Yu ASL, Mrug M, Bennett WM, Harris PC; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):823-833. doi: 10.2215/CJN.10360818. Epub 2019 May 14.

PMID:
31088850
2.

Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.

Yu ASL, Shen C, Landsittel DP, Grantham JJ, Cook LT, Torres VE, Chapman AB, Bae KT, Mrug M, Harris PC, Rahbari-Oskoui FF, Shi T, Bennett WM; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Kidney Int. 2019 May;95(5):1253-1261. doi: 10.1016/j.kint.2018.12.023. Epub 2019 Mar 4.

PMID:
30922668
3.

VA solid organ transplant programs: Maximizing the resources for current and future veterans.

Bennett WM.

Am J Transplant. 2019 May;19(5):1259-1261. doi: 10.1111/ajt.15343. Epub 2019 Mar 26. No abstract available.

PMID:
30838760
4.

Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.

McKenzie KA, El Ters M, Torres VE, Harris PC, Chapman AB, Mrug M, Rahbari-Oskoui FF, Bae KT, Landsittel DP, Bennett WM, Yu ASL, Mahnken JD.

BMC Nephrol. 2018 Dec 27;19(1):378. doi: 10.1186/s12882-018-1182-0.

5.

Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.

Yu ASL, Shen C, Landsittel DP, Harris PC, Torres VE, Mrug M, Bae KT, Grantham JJ, Rahbari-Oskoui FF, Flessner MF, Bennett WM, Chapman AB; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Kidney Int. 2018 Mar;93(3):691-699. doi: 10.1016/j.kint.2017.09.027. Epub 2017 Dec 28.

6.

Renal Cell Carcinoma in Renal Transplantation: The Case for Surveillance.

Bennett WM, Simonich EL, Garre AM, McEvoy KM, Farinola MA, Batiuk TD.

Transplant Proc. 2017 Oct;49(8):1779-1782. doi: 10.1016/j.transproceed.2017.06.031.

PMID:
28923624
7.

Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.

Kline TL, Korfiatis P, Edwards ME, Bae KT, Yu A, Chapman AB, Mrug M, Grantham JJ, Landsittel D, Bennett WM, King BF, Harris PC, Torres VE, Erickson BJ; CRISP Investigators.

Kidney Int. 2017 Nov;92(5):1206-1216. doi: 10.1016/j.kint.2017.03.026. Epub 2017 May 20.

8.

Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease.

Shen C, Landsittel D, Irazabal MV, Yu AS, Chapman AB, Mrug M, Grantham JJ, Bae KT, Bennett WM, Flessner MF, Torres VE; CRISP Investigators.

Am J Kidney Dis. 2017 Mar;69(3):482-484. doi: 10.1053/j.ajkd.2016.10.021. Epub 2016 Dec 24. No abstract available.

9.

Vancomycin Trough Levels: Cause or Result of Acute Kidney Injury?

Bennett WM.

Am J Nephrol. 2016;44(6):454-455. Epub 2016 Oct 28. No abstract available.

10.

Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney disease.

Kim Y, Bae SK, Cheng T, Tao C, Ge Y, Chapman AB, Torres VE, Yu AS, Mrug M, Bennett WM, Flessner MF, Landsittel DP, Bae KT.

Phys Med Biol. 2016 Nov 21;61(22):7864-7880. Epub 2016 Oct 25.

11.

The American Society of Nephrology at 50: A Personal Perspective.

Bennett WM.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):369-71. doi: 10.2215/CJN.11291015. Epub 2016 Feb 18. No abstract available.

12.

Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.

Heyer CM, Sundsbak JL, Abebe KZ, Chapman AB, Torres VE, Grantham JJ, Bae KT, Schrier RW, Perrone RD, Braun WE, Steinman TI, Mrug M, Yu AS, Brosnahan G, Hopp K, Irazabal MV, Bennett WM, Flessner MF, Moore CG, Landsittel D, Harris PC; HALT PKD and CRISP Investigators.

J Am Soc Nephrol. 2016 Sep;27(9):2872-84. doi: 10.1681/ASN.2015050583. Epub 2016 Jan 28.

13.

Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.

Kim Y, Ge Y, Tao C, Zhu J, Chapman AB, Torres VE, Yu AS, Mrug M, Bennett WM, Flessner MF, Landsittel DP, Bae KT; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):576-84. doi: 10.2215/CJN.08300815. Epub 2016 Jan 21.

14.

Early Post-transplant Lymphoproliferative Disease in the Donor Ureter Without Systemic Involvement: A Case Report.

Bennett WM, Batiuk TD, McEvoy KM, Douzdjian V, Hyde J, Shaut C, Segal GM.

Transplant Proc. 2015 Sep;47(7):2301-3. doi: 10.1016/j.transproceed.2015.07.005.

PMID:
26361705
15.

Glomerular endothelial vesicles in a renal allograft: an unusual pattern of immunoglobulin deposition in a patient with biclonal gammopathy of unknown significance.

Flatley EM, Segal GM, Batiuk TD, Bennett WM, Houghton DC, Troxell ML.

Am J Surg Pathol. 2015 Jun;39(6):864-9. doi: 10.1097/PAS.0000000000000406.

PMID:
25723111
16.

Novel methodology to evaluate renal cysts in polycystic kidney disease.

Bae KT, Sun H, Lee JG, Bae K, Wang J, Tao C, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, Flessner MF, Landsittel DP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease.

Am J Nephrol. 2014;39(3):210-7. doi: 10.1159/000358604. Epub 2014 Feb 22.

17.

Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease.

Bae KT, Tao C, Wang J, Kaya D, Wu Z, Bae JT, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, Flessner MF, Landsittel DP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Am J Nephrol. 2013;38(4):333-41. doi: 10.1159/000355375. Epub 2013 Oct 5.

18.

Splenic large B-cell lymphoma 17 years after exposure to aristolochic acid.

Bennett WM, Segal G.

Transplantation. 2013 Oct 15;96(7):e56-7. doi: 10.1097/TP.0b013e3182a5def5. No abstract available.

PMID:
24100848
19.

Drug dosing in elderly patients with chronic kidney disease.

Lassiter J, Bennett WM, Olyaei AJ.

Clin Geriatr Med. 2013 Aug;29(3):657-705. doi: 10.1016/j.cger.2013.05.008.

PMID:
23849014
20.

Images in clinical medicine. Torus palatinus.

Bennett WM.

N Engl J Med. 2013 Apr 11;368(15):1434. doi: 10.1056/NEJMicm1205313. No abstract available.

21.

Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.

Bae K, Park B, Sun H, Wang J, Tao C, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, Flessner MF, Landsittel DP, Bae KT; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2013 Jul;8(7):1089-97. doi: 10.2215/CJN.10561012. Epub 2013 Mar 21.

22.

Enteric oxalate nephropathy in the renal allograft: an underrecognized complication of bariatric surgery.

Troxell ML, Houghton DC, Hawkey M, Batiuk TD, Bennett WM.

Am J Transplant. 2013 Feb;13(2):501-9. doi: 10.1111/ajt.12029. Epub 2013 Jan 11.

23.

Peritransplant management of retained native kidneys in autosomal dominant polycystic kidney disease.

Bennett WM.

Nephrol Dial Transplant. 2013 Feb;28(2):245-6. doi: 10.1093/ndt/gfs176. Epub 2012 Jul 6. No abstract available.

PMID:
22773241
24.

Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ.

Clin J Am Soc Nephrol. 2012 Mar;7(3):479-86. doi: 10.2215/CJN.09500911. Epub 2012 Feb 16.

25.

Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Matzke GR, Aronoff GR, Atkinson AJ Jr, Bennett WM, Decker BS, Eckardt KU, Golper T, Grabe DW, Kasiske B, Keller F, Kielstein JT, Mehta R, Mueller BA, Pasko DA, Schaefer F, Sica DA, Inker LA, Umans JG, Murray P.

Kidney Int. 2011 Dec;80(11):1122-37. doi: 10.1038/ki.2011.322. Epub 2011 Sep 14.

26.

A new system for kidney allocation: the devil is in the details.

Bennett WM, McEvoy KM.

Clin J Am Soc Nephrol. 2011 Sep;6(9):2308-9. doi: 10.2215/CJN.03560411. Epub 2011 Aug 4. No abstract available.

27.

George A. Porter, MD, 1931-2011: a distinguished academic career.

Bennett WM.

Am J Kidney Dis. 2011 May;57(5):xxi-xxii. doi: 10.1053/j.ajkd.2011.03.005. No abstract available.

PMID:
21496722
28.

mTOR inhibitors and autosomal dominant polycystic kidney disease.

Grantham JJ, Bennett WM, Perrone RD.

N Engl J Med. 2011 Jan 20;364(3):286-7; author reply 287-9. doi: 10.1056/NEJMc1010845. No abstract available.

PMID:
21247328
29.

Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.

Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr, Wetzel LH, Martin D, Lockhart ME, Bennett WM, Moxey-Mims M, Abebe KZ, Lin Y, Bost JE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2011 Mar;6(3):640-7. doi: 10.2215/CJN.03250410. Epub 2010 Nov 18.

30.

Kidney transplantation in the morbidly obese: complicated but still better than dialysis.

Bennett WM, McEvoy KM, Henell KR, Pidikiti S, Douzdjian V, Batiuk T.

Clin Transplant. 2011 May-Jun;25(3):401-5. doi: 10.1111/j.1399-0012.2010.01328.x. Epub 2010 Oct 14.

PMID:
20946469
31.

Surveillance and modification of immunosuppression minimizes BK virus nephropathy.

Bennett WM, Meyer L, Ridenour J, Batiuk TD.

Am J Nephrol. 2010;32(1):10-2. doi: 10.1159/000313888. Epub 2010 May 19.

PMID:
20484894
32.

Extension of Medicare immunosuppressive drug benefits: a "no brainer" that did not happen.

Bennett WM.

Clin J Am Soc Nephrol. 2010 May;5(5):743. doi: 10.2215/CJN.01680210. Epub 2010 May 6. No abstract available.

33.

Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantation.

Shihab FS, Bennett WM, Andoh TF.

Am J Nephrol. 2010;31(2):134-40. doi: 10.1159/000259900. Epub 2009 Nov 17.

PMID:
19923799
34.

Drug dosing in the elderly patients with chronic kidney disease.

Olyaei AJ, Bennett WM.

Clin Geriatr Med. 2009 Aug;25(3):459-527. doi: 10.1016/j.cger.2009.04.004. Review.

PMID:
19765493
35.

Autosomal dominant polycystic kidney disease: 2009 update for internists.

Bennett WM.

Korean J Intern Med. 2009 Sep;24(3):165-8. doi: 10.3904/kjim.2009.24.3.165. Epub 2009 Aug 26. Review.

36.

MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.

Bae KT, Tao C, Zhu F, Bost JE, Chapman AB, Grantham JJ, Torres VE, Guay-Woodford LM, Meyers CM, Bennett WM; Consortium for Radiologic Imaging Studies Polycystic Kidney Disease.

Clin J Am Soc Nephrol. 2009 Apr;4(4):719-25. doi: 10.2215/CJN.03750708. Epub 2009 Apr 1.

37.

Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation.

Shihab FS, Bennett WM, Andoh TF.

Transplantation. 2009 Feb 15;87(3):326-9. doi: 10.1097/TP.0b013e3181945332.

PMID:
19202436
38.

Introduction: academic nephrology 2008.

Bennett WM, Schrier RW.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1869. doi: 10.2215/CJN.03630708. Epub 2008 Oct 15. No abstract available.

39.

Reporting eGFR.

Bennett WM.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1561-2. doi: 10.2215/CJN.02870608. Epub 2008 Jul 30. No abstract available.

40.

Use of organs for transplantation from a donor with primary meningoencephalitis due to Naegleria fowleri.

Bennett WM, Nespral JF, Rosson MW, McEvoy KM.

Am J Transplant. 2008 Jun;8(6):1334-5. doi: 10.1111/j.1600-6143.2008.02217.x. Epub 2008 Apr 29.

41.

Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen.

Kamel Mohamed OH, Wahba IM, Watnick S, Earle SB, Bennett WM, Ayres JW, Munar MY.

Clin J Am Soc Nephrol. 2007 Jul;2(4):694-9. Epub 2007 Jun 6.

42.

Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.

Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. Epub 2006 Nov 2.

43.

Patient care guidelines: problems and solutions.

Narins RG, Bennett WM.

Clin J Am Soc Nephrol. 2007 Jan;2(1):1-2. Epub 2006 Dec 6. Review.

44.

Should dialysis patients ever receive warfarin and for what reasons?

Bennett WM.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1357-9. Epub 2006 Sep 27. No abstract available.

45.

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2006 Jan;1(1):64-9. Epub 2005 Oct 26.

46.

Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC; CRISP Consortium.

J Am Soc Nephrol. 2007 Jul;18(7):2143-60. Epub 2007 Jun 20.

47.
48.

Renal transplantation for ADPKD patients: a 2007 update.

Bennett WM.

Nephrol News Issues. 2007 Mar;21(4):24-5, 27. No abstract available.

PMID:
17393922
49.

Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.

Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang QJ, Thompson PA, Zhu F, Miller JP.

J Am Soc Nephrol. 2006 Nov;17(11):3013-9. Epub 2006 Oct 11.

50.

Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental chronic nephrotoxicity.

Shihab FS, Bennett WM, Yi H, Andoh TF.

Am J Nephrol. 2006;26(4):400-7. Epub 2006 Aug 22.

PMID:
16926534

Supplemental Content

Loading ...
Support Center